Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients
Background: Pancreatic adenocarcinoma has a poor prognosis, resulting in a <10% survival rate at 5 years. Modulated electro-hyperthermia (mEHT) has been increasingly used for pancreatic cancer palliative care and therapy. Objective: To monitor the efficacy and safety of mEHT for the treatment of...
Main Authors: | Giammaria Fiorentini MD, Donatella Sarti PhD, Virginia Casadei MD, Carlo Milandri MD, Patrizia Dentico MD, Andrea Mambrini MD, Roberto Nani MD, Caterina Fiorentini MD, Stefano Guadagni MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-09-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/1534735419878505 |
Similar Items
-
Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study
by: Giammaria Fiorentini MD, et al.
Published: (2019-02-01) -
Re: Response to Recommendation of Regional Hyperthermia in the Treatment of Breast Cancer
by: Giammaria Fiorentini MD, et al.
Published: (2021-01-01) -
A Narrative Review of Regional Hyperthermia: Updates From 2010 to 2019
by: Giammaria Fiorentini MD, et al.
Published: (2020-10-01) -
Updates of colorectal cancer liver metastases therapy: review on DEBIRI
by: Giammaria Fiorentini, et al.
Published: (2020-03-01) -
Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
by: Giammaria Fiorentini, et al.
Published: (2022-03-01)